Therapeutic potential (2)

Abstract

Get full access to this article

View all access options for this article.

References

1 Monneaux F Briand J-P Muller S . B and T cell immune response to snRNP in lupus mice. Autoreactive CD4+ T cells recognize a T cell epitope located within the conserved RNP consensus sequence of the 70K protein. Eur J Immunol 2000; 20: 2191 – 2200 .

2 Monneaux F Lozano JM Patarroyo ME Briand J-P Muller S . T cell recognition and therapeutic effects of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MRL/lpr lupus mice. Eur J Immunol 2003; 33: 287 – 296 .

3 Monneaux F Hoebeke J Sordet C . Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analogue. J Immunol 2005; 175: 5839 – 5847 .

4 Monneaux F Muller S

Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences.

Arthritis Rheum 2002; 46: 1430 – 1438 .

5 Monneaux F Parietti V Briand JP Muller S . Intramolecular T cell spreading in unprimed MRL/lpr mice: importance of the U1-70K protein sequence 131–151. Arthritis Rheum 2004; 50: 3232 – 3238 .

6 Bootsma H Spronk P Derksen R . Prevention of relapses in systemic lupus erythematosus. Lancet 1995; 354: 1595 – 1599 .

7 Bijl M Horst G Bootsma H Limburg PC Kallenberg CG . Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk. Ann Rheum Dis 2003; 62: 534 – 539 .

8 Alarcon-Segovia D Tumlin JA Furie RA . LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study. Arthritis Rheum 2003; 48: 442 – 454 .

9 Cardiel MH . Abetimus sodium: a new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease. Expert Opin Investig Drugs 2005; 14: 77 – 88 .

10.

10 Linnik, MD, Hu, JZ, Heilbrunn, KR. Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheum 2005; 52: 1129–1137.